{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:04:21Z","timestamp":1785859461709,"version":"3.56.0"},"reference-count":97,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1097\/01.inf.0000188155.46381.15","type":"journal-article","created":{"date-parts":[[2005,12,23]],"date-time":"2005-12-23T04:01:44Z","timestamp":1135310504000},"page":"S159-S169","source":"Crossref","is-referenced-by-count":54,"title":["Virus-Induced Airway Dysfunction"],"prefix":"10.1097","volume":"24","author":[{"given":"Azzeddine","family":"Dakhama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Mok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin W.","family":"Gelfand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210202","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1165\/ajrcmb.23.5.f204","article-title":"Epithelial regulation of innate immunity to respiratory syncytial virus.","volume":"23","author":"Garofalo","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R2-3-20210202","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00130832-200102000-00012","article-title":"The bronchial epithelium: translating gene and environment interactions in asthma.","volume":"1","author":"Davies","year":"2001","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R3-3-20210202","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1440-1843.2003.00493.x","article-title":"The airway epithelium: structural and functional properties in health and disease.","volume":"8","author":"Knight","year":"2003","journal-title":"Respirology"},{"key":"R4-3-20210202","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1183\/09031936.03.00098803","article-title":"Innate immunity in the lung: how epithelial cells fight against respiratory pathogens.","volume":"23","author":"Bals","year":"2004","journal-title":"Eur Respir J"},{"key":"R5-3-20210202","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/CMR.14.4.778-809.2001","article-title":"Antiviral actions of interferons.","volume":"14","author":"Samuel","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"R6-3-20210202","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/ni1102-1013","article-title":"To kill or be killed: viral evasion of apoptosis.","volume":"3","author":"Benedict","year":"2002","journal-title":"Nat Immunol"},{"key":"R7-3-20210202","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1600-065X.1999.tb01287.x","article-title":"Immune evasion by adenoviruses.","volume":"168","author":"Mahr","year":"1999","journal-title":"Immunol Rev"},{"key":"R8-3-20210202","first-page":"3","article-title":"Evasion of the immune system by adenoviruses.","volume":"273","author":"Blair","year":"2004","journal-title":"Curr Top Microbiol Immunol"},{"key":"R9-3-20210202","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.coi.2004.11.009","article-title":"Viral immune evasion molecules attack the ER peptide-loading complex and exploit ER-associated degradation pathways.","volume":"17","author":"Lybarger","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"R10-3-20210202","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1286-4579(00)01363-0","article-title":"Pulmonary collectins and innate host defense of the lung.","volume":"3","author":"LeVine","year":"2001","journal-title":"Microbes Infect"},{"key":"R11-3-20210202","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000080899","article-title":"Insights into the pathogenesis of asthma utilizing murine models.","volume":"135","author":"Taube","year":"2004","journal-title":"Int Arch Allergy Immunol"},{"key":"R12-3-20210202","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1073\/pnas.88.5.1651","article-title":"A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia.","volume":"88","author":"Ginsberg","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"R13-3-20210202","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/jmv.10475","article-title":"Acute inflammatory response and remodeling of airway epithelium after subspecies B1 human adenovirus infection of the mouse lower respiratory tract.","volume":"71","author":"Kajon","year":"2003","journal-title":"J Med Virol"},{"key":"R14-3-20210202","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1074-7613(00)80573-7","article-title":"Virus-specific CD8+ T cells in primary and secondary influenza pneumonia.","volume":"8","author":"Flynn","year":"1998","journal-title":"Immunity"},{"key":"R15-3-20210202","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/jmv.1890260207","article-title":"Primary respiratory syncytial virus infection in mice.","volume":"26","author":"Graham","year":"1988","journal-title":"J Med Virol"},{"issue":"4,","key":"R16-3-20210202","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1164\/ajrccm\/152.4_Pt_2.S59","article-title":"Immunity and immunopathology to respiratory syncytial virus. The mouse model.","volume":"152","author":"Openshaw","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"R17-3-20210202","doi-asserted-by":"crossref","first-page":"14003","DOI":"10.1128\/JVI.78.24.14003-14011.2004","article-title":"Human metapneumovirus persists in BALB\/c mice despite the presence of neutralizing antibodies.","volume":"78","author":"Alvarez","year":"2004","journal-title":"J Virol"},{"key":"R18-3-20210202","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1172\/JCI0214345","article-title":"Viral induction of a chronic asthma phenotype and genetic segregation from the acute response.","volume":"110","author":"Walter","year":"2002","journal-title":"J Clin Invest"},{"key":"R19-3-20210202","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1128\/JVI.77.2.1237-1244.2003","article-title":"Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agents.","volume":"77","author":"Bonville","year":"2003","journal-title":"J Virol"},{"key":"R20-3-20210202","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1099\/0022-1317-79-10-2411","article-title":"Pathogenesis of pneumovirus infections in mice: detection of pneumonia virus of mice and human respiratory syncytial virus mRNA in lungs of infected mice by in situ hybridization.","volume":"79","author":"Cook","year":"1998","journal-title":"J Gen Virol"},{"key":"R21-3-20210202","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1172\/JCI119516","article-title":"Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen.","volume":"100","author":"Schwarze","year":"1997","journal-title":"J Clin Invest"},{"key":"R22-3-20210202","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.4049\/jimmunol.126.3.1036","article-title":"Recovery from a viral respiratory infection. I. Influenza pneumonia in normal and T-deficient mice.","volume":"126","author":"Wells","year":"1981","journal-title":"J Immunol"},{"key":"R23-3-20210202","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1164\/rccm.200308-1203OC","article-title":"Latency and persistence of respiratory syncytial virus despite T cell immunity.","volume":"169","author":"Schwarze","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R25-3-20210202","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1152\/japplphysiol.00706.2002","article-title":"Measuring lung function in mice: the phenotyping uncertainty principle.","volume":"94","author":"Bates","year":"2003","journal-title":"J Appl Physiol"},{"issue":"6","key":"R26-3-20210202","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1164\/ajrccm.157.6.9707163","article-title":"Virus-induced airway hyperresponsiveness and asthma.","volume":"157","author":"Folkerts","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"R27-3-20210202","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1084\/jem.20041901","article-title":"Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus.","volume":"201","author":"Wark","year":"2005","journal-title":"J Exp Med"},{"key":"R28-3-20210202","doi-asserted-by":"crossref","first-page":"6S","DOI":"10.1016\/S0012-3692(15)41137-7","article-title":"Pathology of chronic airflow obstruction.","volume":"97","author":"Thurlbeck","year":"1990","journal-title":"Chest"},{"key":"R29-3-20210202","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1440-1681.1995.tb02028.x","article-title":"Mechanisms of increased airway microvascular permeability: role in airway inflammation and obstruction.","volume":"22","author":"Goldie","year":"1995","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R30-3-20210202","first-page":"589","article-title":"The functional consequences of airway remodeling in asthma.","volume":"52","author":"Pare","year":"1997","journal-title":"Monaldi Arch Chest Dis"},{"key":"R31-3-20210202","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jama.287.6.755","article-title":"Virus-induced asthma attacks.","volume":"287","author":"Jacoby","year":"2002","journal-title":"JAMA"},{"key":"R32-3-20210202","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0014-2999(90)90244-Z","article-title":"Parainfluenza virus type 1 reduces the affinity of agonists for muscarinic receptors in guinea-pig lung and heart.","volume":"181","author":"Fryer","year":"1990","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"R33-3-20210202","first-page":"21","article-title":"Neural control mechanisms within airways: disruption by respiratory syncytial virus.","volume":"135","author":"Larsen","year":"1999","journal-title":"J Pediatr"},{"key":"R34-3-20210202","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1128\/JVI.74.4.1614-1622.2000","article-title":"Respiratory syncytial virus infection and G and\/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB\/c mice.","volume":"74","author":"Tripp","year":"2000","journal-title":"J Virol"},{"key":"R35-3-20210202","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0165-5728(02)00169-8","article-title":"Substance P receptor expression on lymphocytes is associated with the immune response to respiratory syncytial virus infection.","volume":"129","author":"Tripp","year":"2002","journal-title":"J Neuroimmunol"},{"key":"R36-3-20210202","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1165\/ajrcmb.24.2.4264","article-title":"Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats.","volume":"24","author":"King","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R37-3-20210202","doi-asserted-by":"crossref","first-page":"L105","DOI":"10.1152\/ajplung.00004.2003","article-title":"Immunomodulatory effects of sensory nerves during respiratory syncytial virus infection in rats.","volume":"285","author":"Auais","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R38-3-20210202","doi-asserted-by":"crossref","first-page":"L761","DOI":"10.1152\/ajplung.00143.2004","article-title":"Alteration of airway neuropeptide expression and development of airway hyperresponsiveness following respiratory syncytial virus infection.","volume":"288","author":"Dakhama","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R39-3-20210202","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.coph.2004.01.006","article-title":"Calcitonin gene-related peptide: role in airway homeostasis.","volume":"4","author":"Dakhama","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"R40-3-20210202","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1086\/386372","article-title":"Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice.","volume":"189","author":"Jafri","year":"2004","journal-title":"J Infect Dis"},{"key":"R41-3-20210202","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1172\/JCI115362","article-title":"Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.","volume":"88","author":"Graham","year":"1991","journal-title":"J Clin Invest"},{"key":"R42-3-20210202","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1084\/jem.20020943","article-title":"Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood.","volume":"196","author":"Culley","year":"2002","journal-title":"J Exp Med"},{"key":"R43-3-20210202","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.4049\/jimmunol.173.2.1298","article-title":"Induction and maintenance of airway responsiveness to allergen challenge are determined at the age of initial sensitization.","volume":"173","author":"Gelfand","year":"2004","journal-title":"J Immunol"},{"key":"R44-3-20210202","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.4049\/jimmunol.175.3.1876","article-title":"The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production.","volume":"175","author":"Dakhama","year":"2005","journal-title":"J Immunol"},{"key":"R45-3-20210202","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1126\/science.282.5397.2258","article-title":"Interleukin-13: central mediator of allergic asthma.","volume":"282","author":"Wills-Karp","year":"1998","journal-title":"Science"},{"key":"R46-3-20210202","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nm734","article-title":"Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma.","volume":"8","author":"Kuperman","year":"2002","journal-title":"Nat Med"},{"key":"R47-3-20210202","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.4049\/jimmunol.167.8.4668","article-title":"Critical role for IL-13 in the development of allergen-induced airway hyperreactivity.","volume":"167","author":"Walter","year":"2001","journal-title":"J Immunol"},{"key":"R48-3-20210202","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.4049\/jimmunol.169.11.6482","article-title":"The role of IL-13 in established allergic airway disease.","volume":"169","author":"Taube","year":"2002","journal-title":"J Immunol"},{"key":"R49-3-20210202","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.jaci.2003.08.046","article-title":"Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen.","volume":"112","author":"Park","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"R50-3-20210202","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJM198011203032103","article-title":"The appearance of cell-bound IgE in respiratory-tract epithelium after respiratory-syncytial-virus infection.","volume":"303","author":"Welliver","year":"1980","journal-title":"N Engl J Med"},{"key":"R51-3-20210202","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1164\/rccm.200311-1610OC","article-title":"The role of virus-specific immunoglobulin E in airway hyperresponsiveness.","volume":"170","author":"Dakhama","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R52-3-20210202","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0091-6749(79)90106-4","article-title":"Development of allergy in children. I. Association with virus infections.","volume":"63","author":"Frick","year":"1979","journal-title":"J Allergy Clin Immunol"},{"key":"R53-3-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2222.1989.tb02336.x","article-title":"The relationship between viral infections and onset of allergic diseases and asthma.","volume":"19","author":"Busse","year":"1989","journal-title":"Clin Exp Allergy"},{"key":"R54-3-20210202","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1164\/rccm.200406-730OC","article-title":"Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13.","volume":"171","author":"Sigurs","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R55-3-20210202","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ppul.20058","article-title":"Respiratory morbidity 20 years after RSV infection in infancy.","volume":"38","author":"Korppi","year":"2004","journal-title":"Pediatr Pulmonol"},{"key":"R56-3-20210202","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(98)10321-5","article-title":"Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years.","volume":"354","author":"Stein","year":"1999","journal-title":"Lancet"},{"key":"R57-3-20210202","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0952-7915(00)00155-2","article-title":"The influence of infections on the development and severity of allergic disorders.","volume":"12","author":"Herz","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"R58-3-20210202","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1183\/09031936.02.00254302","article-title":"Respiratory viral infections as promoters of allergic sensitization and asthma in animal models.","volume":"19","author":"Schwarze","year":"2002","journal-title":"Eur Respir J"},{"key":"R59-3-20210202","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1046\/j.1365-2222.1998.00438.x","article-title":"Anaphylactic sensitization to aeroantigen during respiratory virus infection.","volume":"28","author":"O'Donnell","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"R60-3-20210202","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.4049\/jimmunol.169.10.5458","article-title":"Antigen-nonspecific recruitment of Th2 cells to the lung as a mechanism for viral infection-induced allergic asthma.","volume":"169","author":"Stephens","year":"2002","journal-title":"J Immunol"},{"key":"R61-3-20210202","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/eji.200323930","article-title":"Respiratory syncytial virus-induced CCL5\/RANTES contributes to exacerbation of allergic airway inflammation.","volume":"33","author":"John","year":"2003","journal-title":"Eur J Immunol"},{"key":"R62-3-20210202","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0091-6749(03)02020-7","article-title":"Prior airway exposure to allergen increases virus-induced airway hyperresponsiveness.","volume":"112","author":"Makela","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"R63-3-20210202","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.4049\/jimmunol.163.10.5729","article-title":"Transfer of the enhancing effect of respiratory syncytial virus infection on subsequent allergic airway sensitization by T lymphocytes.","volume":"163","author":"Schwarze","year":"1999","journal-title":"J Immunol"},{"key":"R64-3-20210202","doi-asserted-by":"crossref","first-page":"6583","DOI":"10.4049\/jimmunol.164.12.6583","article-title":"Recurrent respiratory syncytial virus infections in allergen-sensitized mice lead to persistent airway inflammation and hyperresponsiveness.","volume":"164","author":"Matsuse","year":"2000","journal-title":"J Immunol"},{"key":"R65-3-20210202","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1086\/324429","article-title":"Immune interaction between respiratory syncytial virus infection and allergen sensitization critically depends on timing of challenges.","volume":"184","author":"Peebles","year":"2001","journal-title":"J Infect Dis"},{"key":"R66-3-20210202","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1086\/386341","article-title":"Timing of infection and prior immunization with respiratory syncytial virus (RSV) in RSV-enhanced allergic inflammation.","volume":"189","author":"Barends","year":"2004","journal-title":"J Infect Dis"},{"issue":"2","key":"R68-3-20210202","first-page":"2","article-title":"Respiratory syncytial virus: a continuing culprit and conundrum.","volume":"135","author":"Hall","year":"1999","journal-title":"J Pediatr"},{"issue":"suppl 5","key":"R69-3-20210202","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1067\/S0022-3476(03)00508-0","article-title":"Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection.","volume":"143","author":"Welliver","year":"2003","journal-title":"J Pediatr"},{"issue":"3","key":"R70-3-20210202","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1164\/ajrccm.163.supplement_1.2011109","article-title":"Epidemiologic and clinical evidence of a respiratory syncytial virus-reactive airway disease link.","volume":"163","author":"Sigurs","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R71-3-20210202","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1183\/09031936.01.00254101","article-title":"Relationship between respiratory syncytial virus bronchiolitis and future obstructive airway diseases.","volume":"18","author":"Wennergren","year":"2001","journal-title":"Eur Respir J"},{"key":"R73-3-20210202","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.prrv.2004.01.007","article-title":"Asthma phenotypes in childhood: lessons from an epidemiological approach.","volume":"5","author":"Stein","year":"2004","journal-title":"Paediatr Respir Rev"},{"key":"R74-3-20210202","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10446670410001722131","article-title":"Progress in defining the role of RSV in allergy and asthma: from clinical observations to animal models.","volume":"11","author":"Kalina","year":"2004","journal-title":"Clin Dev Immunol"},{"key":"R75-3-20210202","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/rmv.423","article-title":"New drugs and treatment for respiratory syncytial virus.","volume":"14","author":"Maggon","year":"2004","journal-title":"Rev Med Virol"},{"key":"R76-3-20210202","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/adc.87.6.546","article-title":"How do we treat wheezing infants? Evidence or anecdote.","volume":"87","author":"Chavasse","year":"2002","journal-title":"Arch Dis Child"},{"issue":"2","key":"R77-3-20210202","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1542\/peds.100.2.233","article-title":"Efficacy of beta2-agonists in bronchiolitis: a reappraisal and meta-analysis.","volume":"100","author":"Flores","year":"1997","journal-title":"Pediatrics"},{"key":"R78-3-20210202","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1001\/archpedi.158.2.127","article-title":"Pharmacologic treatment of bronchiolitis in infants and children: a systematic review.","volume":"158","author":"King","year":"2004","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R79-3-20210202","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s001340050791","article-title":"Effect of inhaled nitric oxide on respiratory mechanics in ventilated infants with RSV bronchiolitis.","volume":"25","author":"Patel","year":"1999","journal-title":"Intensive Care Med"},{"issue":"4","key":"R80-3-20210202","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1164\/ajrccm.162.4.9909004","article-title":"Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis.","volume":"162","author":"Tibby","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R81-3-20210202","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00130478-200207000-00011","article-title":"Multicenter, randomized, controlled study of porcine surfactant in severe respiratory syncytial virus-induced respiratory failure.","volume":"3","author":"Luchetti","year":"2002","journal-title":"Pediatr Crit Care Med"},{"key":"R82-3-20210202","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1542\/peds.109.1.68","article-title":"Heliox therapy in infants with acute bronchiolitis.","volume":"109","author":"Martinon-Torres","year":"2002","journal-title":"Pediatrics"},{"key":"R83-3-20210202","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nrd1524","article-title":"New drugs for asthma.","volume":"3","author":"Barnes","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"R84-3-20210202","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/adc.82.2.126","article-title":"Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis.","volume":"82","author":"Cade","year":"2000","journal-title":"Arch Dis Child"},{"key":"R85-3-20210202","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/bmj.315.7112.858","article-title":"Effect of inhaled corticosteroids on episodes of wheezing associated with viral infection in school age children: randomised double blind placebo controlled trial.","volume":"315","author":"Doull","year":"1997","journal-title":"BMJ"},{"key":"R86-3-20210202","doi-asserted-by":"crossref","first-page":"E44","DOI":"10.1542\/peds.105.4.e44","article-title":"Systemic corticosteroids in infant bronchiolitis: a meta-analysis.","volume":"105","author":"Garrison","year":"2000","journal-title":"Pediatrics"},{"key":"R87-3-20210202","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/1099-0496(200008)30:2<92::AID-PPUL3>3.0.CO;2-X","article-title":"Long-term effects of prednisolone in the acute phase of bronchiolitis caused by respiratory syncytial virus.","volume":"30","author":"van Woensel","year":"2000","journal-title":"Pediatr Pulmonol"},{"key":"R88-3-20210202","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1034\/j.1399-3003.2000.15b27.x","article-title":"No objective benefit from steroids inhaled via a spacer in infants recovering from bronchiolitis.","volume":"15","author":"Wong","year":"2000","journal-title":"Eur Respir J"},{"key":"R89-3-20210202","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJM199107043250105","article-title":"A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection.","volume":"325","author":"Smith","year":"1991","journal-title":"N Engl J Med"},{"key":"R90-3-20210202","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1164\/ajrccm.160.3.9810013","article-title":"Ribavirin in ventilated respiratory syncytial virus bronchiolitis. A randomized, placebo-controlled trial.","volume":"160","author":"Guerguerian","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"R91-3-20210202","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/00006454-199711000-00004","article-title":"Long term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin or placebo.","volume":"16","author":"Long","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"R92-3-20210202","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nm1164","article-title":"Inhibition of respiratory viruses by nasally administered siRNA.","volume":"11","author":"Bitko","year":"2005","journal-title":"Nat Med"},{"key":"R93-3-20210202","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nm1174","article-title":"Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene.","volume":"11","author":"Zhang","year":"2005","journal-title":"Nat Med"},{"key":"R94-3-20210202","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/oxfordjournals.aje.a120956","article-title":"Respiratory virus immunization, I: a field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine.","volume":"89","author":"Fulginiti","year":"1969","journal-title":"Am J Epidemiol"},{"issue":"4","key":"R95-3-20210202","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1164\/ajrccm\/152.4_Pt_2.S63","article-title":"Pathogenesis of respiratory syncytial virus vaccine-augmented pathology.","volume":"152","author":"Graham","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"suppl A","key":"R96-3-20210202","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/S1526-0542(04)90024-3","article-title":"Respiratory syncytial virus infection: therapy and prevention.","volume":"5","author":"Welliver","year":"2004","journal-title":"Paediatr Respir Rev"},{"issue":"6","key":"R97-3-20210202","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1542\/peds.112.6.1447","article-title":"American Academy of Pediatrics Committee on Infectious Disease and Committee on Fetus and Newborn. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.","volume":"112","author":"Meissner","year":"2003","journal-title":"Pediatrics"},{"key":"R98-3-20210202","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJM199311183292102","article-title":"Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group.","volume":"329","author":"Groothuis","year":"1993","journal-title":"N Engl J Med"},{"key":"R99-3-20210202","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1542\/peds.99.1.93","article-title":"Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis.","volume":"99","year":"1997","journal-title":"Pediatrics"},{"issue":"3","key":"R100-3-20210202","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants.","volume":"102","year":"1998","journal-title":"Pediatrics"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003453-199942110-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:11:27Z","timestamp":1785856287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-200511001-00003"}},"subtitle":["Pathogenesis and Biomechanisms"],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":97,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.inf.0000188155.46381.15","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}